Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|June 11, 2014
- June 2014
- Volume 18
- Issue 1
Bad Sunburn During Youth May Increase Skin Cancer Risk
Advertisement
Young women who experience multiple severe sunburns may be at an increased risk for melanoma, according to the results of a recent study published online on June 2, 2014, in Cancer Epidemiology, Biomarkers & Prevention. White women who reported having 5 or more blistering sunburns between 15 and 20 years of age were 80% more likely to develop melanoma and 68% more likely to develop basal cell carcinoma and squamous cell carcinoma.
Articles in this issue
over 12 years ago
Consuming Antioxidants and Fish May Prevent Macular Degenerationover 12 years ago
Test May Aid Diagnosis of Fungal Nail Infectionover 12 years ago
18 Years Strong!over 12 years ago
Pharmacy Times: Leading the Wayover 12 years ago
Odd Allergies: OTC Answers?over 12 years ago
Vitamin D Supplements: Reaping the Benefits from the Right Amountover 12 years ago
Teens Frequently Given Opioids for Headacheover 12 years ago
For Plaque Removal, Straight Toothbrush Beats Angledover 12 years ago
Aspirin May Reduce Ovarian Cancer RiskAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists
3
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
4
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
5